ARIX — Arix Bioscience Share News
0.000.00%
- £183.80m
- £82.85m
- £0.11m
Brief: Arix Bioscience Total NAV Of £228.5 MLN As At 31 October 2023
Brief: RTW Biotech To Acquire Arix Bioscience's Assets
RTW Biotech to acquire Arix Bioscience's assets
Brief: Arix Bioscience Says Board Exploring Range Of Strategic Options For Co
Brief: Arix Bioscience Says CEO Robert Lyne To Step Down From Position
Press Digest: British Business - July 14
Arix Bioscience announces strategic review, shares jump
Brief: Arix Bioscience PLC Announces Strategic Review
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
Leads $50 Mln Series B Financing For Evommune
Brief: Arix Bioscience Says Portfolio Company Harpoon Therapeutics Announces Closing Of $25 Million Private Placement
Brief: Arix Bioscience Says Portfolio Co Disc Medicine Announces $62.5 Mln Financing
Brief: Arix Bioscience Says Chairman Peregrine Moncreiffe Purchased 200,000 Ordinary Shares Of 0.001P Each In Co
Director/PDMR Shareholding
Brief: Arix Bioscience Says Chairman Peregrine Moncreiffe Purchased 50,000 Shares At 1.04P/Share
Brief: Arix Bioscience Says Portfolio Co Imara Announces Merger Deal With Enliven Therapeutics